2m 2m 2m 2m 2m 2m 2m
Manzo Pharmaceut (MNZO)
OTC
$0.000001-$0.00010 (-99.00%)
Price as of Jul 23, 2026- N/AMarket Cap
- 0.00%1-Year Change
- Shell CompaniesIndustry
Manzo Pharmaceut (MNZO)
$0.000001-$0.00010 (-99.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.0001
$0.000001
Latest Close$0.000001
Change
-$0.00010 (-9,900.00%)
Volume295
Information as of 07/23/2026
Company Profile
FORTUNE OIL & GAS INC
https://www.lactofreedom.comN/A
Market Cap
N/A
Net Income
Sector: Financial Services
Industry: Shell Companies
PO Box 107, Milford, PA, United States, 18337
570-249-6000Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Key Executives
- Kenneth Manzo
Current Ownership Distribution
- Other1.2B (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)